BARD1 and breast cancer: MSH3 also directly and indirectly interacts with breast cancer susceptibility gene product (BRCA1) and BRCA1-associated RING domain protein 1 (BARD1) which may partially provide an explanation for the background of gynecological and CRC in both Lynch syndrome and BRCA1 individuals [34].